Drugs
LYON, FRANCE: Product Revenue Guidance for 2015 of $170-$185 Million Reaffirmed; Conference Call With Management to Take Place at 10:00 am ET on July 30, 2015 ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 07/29/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on Augus ...
SOUTH SAN FRANCISCO, CA: Theravance Declares a $0.25 per Share Dividend for Q3 2015; Theravance to Host Conference Call and Webcast Today at 5:00 p.m. EDT ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 07/28/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial ...
TAMPA, FL: Infectious Disease Expert Urges Those Experiencing Symptoms to Consult Their Doctors for Proper Care ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 07/24/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight") a leading Canadian specialty pharmaceutical company, today announced the signing of an exclu ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 07/24/15 -- Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink") is pleased to announce that on July 20, 2015, Hepalink acquired 13,270,000 units (& ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 07/23/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the Company will release its financial results for the second quarter 2015 on Thursday, August ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/22/15 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will report financial results for the second quarter ended June 30, 2015 after market c ...
ATLANTA, GEORGIA and MONTREAL, QUEBEC: ATLANTA, GEORGIA and MONTREAL, QUEBEC -- (Marketwired) -- 07/21/15 -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the research, developm ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 07/14/15 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/13/15 -- Theravance, Inc. (NASDAQ: THRX) today announced the appointment of Michael E. Faerm as Senior Vice President and Chief Business Officer. Mr. Fa ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 07/09/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has invested i ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 07/09/15 -- (NASDAQ: CBLI) today announced that it has successfully closed a private placement with David Davidovich, a venture capital investor, for the sale of 6,459 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/08/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 07/07/15 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries, ("Knight") announced today that it has expanded its inno ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 07/02/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has entered in ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 06/26/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...
